{"id":"https://openalex.org/W2123015247","doi":"https://doi.org/10.1111/dom.12181","title":"A novel long\u2010acting glucose\u2010dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents","display_name":"A novel long\u2010acting glucose\u2010dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents","alternate_titles":[],"publication_year":2013,"publication_date":"2013-08-19","ids":{"openalex":"https://openalex.org/W2123015247","doi":"https://doi.org/10.1111/dom.12181","mag":"2123015247","pmid":"https://pubmed.ncbi.nlm.nih.gov/23859463","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4237114"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12181","doi":"https://doi.org/10.1111/dom.12181","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12181","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12181","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2123015247"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12181","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071153791","display_name":"Krystyna Tatarkiewicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"K. Tatarkiewicz","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111709716","display_name":"D. M. Hargrove","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. M. Hargrove","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068297947","display_name":"Carolyn M. Jodka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. M. Jodka","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113552209","display_name":"Bronislava R. Gedulin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. R. Gedulin","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"P. A. Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. A. Smith","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113571668","display_name":"Jonah A. Hoyt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. A. Hoyt","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014715360","display_name":"Aung N. Lwin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Lwin","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059070572","display_name":"Logan Collins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Collins","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025660078","display_name":"\u041b. \u0422. \u041c\u0430\u043c\u0435\u0434\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0002-4719-1866","observed_orcids":["https://orcid.org/0000-0002-4719-1866"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Mamedova","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010965065","display_name":"Odile E. Levy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"O. E. Levy","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048864888","display_name":"Lawrence J. D\u2019Souza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. D'Souza","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049605590","display_name":"Sarah M. Janssen","orcid":"https://orcid.org/0000-0002-5723-1112","observed_orcids":["https://orcid.org/0000-0002-5723-1112","https://orcid.org/0000-0002-6932-5191"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Janssen","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019155047","display_name":"Varnika Srivastava","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. Srivastava","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019318755","display_name":"Soumitra Ghosh","orcid":"https://orcid.org/0000-0002-8376-8677","observed_orcids":["https://orcid.org/0000-0002-8376-8677"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. S. Ghosh","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077809872","display_name":"David G. Parkes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. G. Parkes","raw_affiliation_strings":["Amylin Pharmaceuticals; LLC; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals; LLC; San Diego CA USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5071153791"],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":2.2987,"has_fulltext":true,"cited_by_count":36,"citation_normalized_percentile":{"value":0.87796965,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"16","issue":"1","first_page":"75","last_page":"85"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.029200000688433647,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.9660000205039978},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.7900000214576721},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.6669999957084656},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9639999866485596},{"id":"https://openalex.org/keywords/gip-receptor","display_name":"GIP receptor","score":0.7049999833106995},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.6930000185966492},{"id":"https://openalex.org/keywords/metabolic-stability","display_name":"metabolic stability","score":0.718999981880188},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.8289999961853027},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.578000009059906},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8057146072387695},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7678083181381226},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7524325847625732},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.6724575161933899},{"id":"https://openalex.org/C2776129832","wikidata":"https://www.wikidata.org/wiki/Q22677256","display_name":"Gastric inhibitory polypeptide","level":4,"score":0.6591219305992126},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5289607048034668},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5035673975944519},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.46684202551841736},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.45289814472198486},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40998509526252747},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4027380049228668},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4006405770778656},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.324901282787323},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2019241452217102},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.11846062541007996},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008820","descriptor_name":"Mice, Obese","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011924","descriptor_name":"Rats, Zucker","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/dom.12181","doi":"https://doi.org/10.1111/dom.12181","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12181","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12181","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4237114","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4237114/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:23859463","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23859463","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/dom.12181","doi":"https://doi.org/10.1111/dom.12181","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12181","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12181","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2123015247.pdf","grobid_xml":"https://content.openalex.org/works/W2123015247.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1932403114","https://openalex.org/W1964575982","https://openalex.org/W1964854428","https://openalex.org/W1967295307","https://openalex.org/W1968995247","https://openalex.org/W1969932276","https://openalex.org/W1978953702","https://openalex.org/W1979041860","https://openalex.org/W1979535675","https://openalex.org/W1982526723","https://openalex.org/W1988234896","https://openalex.org/W1988352662","https://openalex.org/W1991579784","https://openalex.org/W1992452630","https://openalex.org/W1997010909","https://openalex.org/W1998890233","https://openalex.org/W2008082500","https://openalex.org/W2023779179","https://openalex.org/W2025485914","https://openalex.org/W2027593203","https://openalex.org/W2029734053","https://openalex.org/W2032541516","https://openalex.org/W2037741963","https://openalex.org/W2044327170","https://openalex.org/W2046352176","https://openalex.org/W2051743127","https://openalex.org/W2054867747","https://openalex.org/W2059180047","https://openalex.org/W2059399687","https://openalex.org/W2081242423","https://openalex.org/W2082908456","https://openalex.org/W2089109393","https://openalex.org/W2093340710","https://openalex.org/W2096704002","https://openalex.org/W2108718885","https://openalex.org/W2115306377","https://openalex.org/W2115778460","https://openalex.org/W2157068658","https://openalex.org/W2170232513"],"related_works":["https://openalex.org/W1985921802","https://openalex.org/W2002861790","https://openalex.org/W1988234896","https://openalex.org/W2028479574","https://openalex.org/W2071778655","https://openalex.org/W1999609515","https://openalex.org/W1996796636","https://openalex.org/W2233805588","https://openalex.org/W2081081330","https://openalex.org/W2125364438"],"abstract_inverted_index":{"AIM:":[0],"Glucose-dependent":[1],"insulinotropic":[2,105,204,221],"peptide":[3,44],"(GIP)":[4],"is":[5,10],"an":[6,115],"incretin":[7],"hormone":[8],"that":[9],"released":[11],"from":[12],"intestinal":[13],"K":[14],"cells":[15],"in":[16,88,97,109,120,137,153,184,197,206],"response":[17],"to":[18,23,82,187,249],"nutrient":[19],"ingestion.":[20],"We":[21],"aimed":[22],"investigate":[24],"the":[25,29,48,51,56,66,83,161,258,268],"therapeutic":[26],"potential":[27,259],"of":[28,50,55,73,80,132,149,203,225,261,270],"novel":[30,263],"N-":[31],"and":[32,78,100,113,122,140,189,199,210,229,240],"C-terminally":[33],"modified":[34],"GIP":[35,61,84,168,181,188,209,264],"analogue":[36,62,163,265],"AC163794.":[37],"METHODS:":[38],"AC163794":[39,81,133,150,177,192,216,242,266],"was":[40,95,193],"synthesized":[41],"by":[42],"solid-phase":[43],"synthesis.":[45],"Design":[46],"involved":[47],"substitution":[49],"C-terminus":[52],"tail":[53,71],"region":[54,72],"dipeptidyl":[57],"peptidase":[58],"IV":[59],"(DPP-IV)-resistant":[60],"[d-Ala(2)":[63,170,190,211],"]GIP(1-42)":[64,171],"with":[65,159,233,252],"unique":[67],"nine":[68],"amino":[69],"acid":[70],"exenatide.":[74,166],"The":[75,129],"functional":[76,180],"activity":[77],"binding":[79],"receptor":[85,182],"were":[86,107,134,151,172],"evaluated":[87],"RIN-m5F":[89],"\u03b2-cells.":[90],"In":[91,213],"vitro":[92,185,198],"metabolic":[93],"stability":[94],"tested":[96,152],"human":[98],"plasma":[99],"kidney":[101],"membrane":[102],"preparations.":[103],"Acute":[104,146],"effects":[106,148,236],"investigated":[108],"isolated":[110],"mouse":[111],"islets":[112],"during":[114],"intravenous":[116],"glucose":[117],"tolerance":[118],"test":[119],"normal":[121],"diabetic":[123,126,144,214],"Zucker":[124],"fatty":[125],"(ZDF)":[127],"rats.":[128],"biological":[130],"actions":[131],"comprehensively":[135],"assessed":[136],"normal,":[138],"ob/ob":[139],"high-fat-fed":[141],"streptozotocin":[142],"(STZ)-induced":[143],"mice.":[145],"glucoregulatory":[147],"diet-induced":[154],"obese":[155],"mice":[156,250],"treated":[157,251],"subchronically":[158],"AC3174,":[160],"exendatide":[162],"[Leu(14)":[164],"]":[165],"Human":[167],"or":[169],"used":[173],"for":[174,267],"comparison.":[175],"RESULTS:":[176],"exhibited":[178],"nanomolar":[179],"potency":[183],"similar":[186],"]GIP(1-42).":[191,212],"metabolically":[194],"more":[195],"stable":[196],"displayed":[200],"longer":[201],"duration":[202],"action":[205],"vivo":[207],"versus":[208],"mice,":[215],"improved":[217,230],"HbA1c":[218],"through":[219],"enhanced":[220],"action,":[222],"partial":[223],"restoration":[224],"pancreatic":[226],"insulin":[227,231],"content":[228],"sensitivity":[232],"no":[234],"adverse":[235],"on":[237],"fat":[238],"storage":[239],"metabolism.":[241],"provided":[243],"additional":[244],"baseline":[245],"glucose-lowering":[246],"when":[247],"injected":[248],"AC3174.":[253],"CONCLUSIONS:":[254],"These":[255],"studies":[256],"support":[257],"use":[260],"a":[262],"treatment":[269],"type":[271],"2":[272],"diabetes.":[273]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2123015247","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
